Keratin 19-positive cutaneous squamous cell carcinoma with elevated serum cytokeratin 19 fragment 21-1 level: A case report

被引:2
|
作者
Ueda, Misato [1 ]
Yasuda, Michinori [1 ]
Shibaoka, Yoshie [1 ]
Kurokawa, Ichiro [2 ]
Kakuno, Ayako [3 ]
Tsubura, Airo [4 ]
机构
[1] Meiwa Hosp, Dept Plast & Reconstruct Surg, Nishinomiya, Hyogo 6638186, Japan
[2] Meiwa Hosp, Dept Dermatol, 4-31 Agenaruo Cho, Nishinomiya, Hyogo 6638186, Japan
[3] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo 6638186, Japan
[4] Kansai Med Univ, Dept Pathol, Nishinomiya, Hyogo 6638186, Japan
关键词
cytokeratin; 19; fragment; 21-1; keratin; primary cutaneous squamous cell carcinoma;
D O I
10.3892/mco.2016.834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokeratin 19 fragment 21-1 (CYFRA21-1) is a marker of lung cancer useful for evaluating clinical diagnosis and prognosis. To the best of our knowledge, there have been no reports of cutaneous squamous cell carcinoma (SCC) with high levels of CYFRA21-1 to date. We herein report a case of a 79-year-old man with a large subcutaneous tumor of the left shoulder, which was diagnosed as primary cutaneous poorly differentiated SCC. The tumor nests were composed of poorly differentiated atypical squamous cells exhibiting high-grade malignancy and mitotic figures; multinuclear cells were also identified inside lymph vessels. Keratin 19 (K19) was intensely expressed in tumor cells. A significantly elevated level of CYFRA21-1 (33 ng/ml) was observed preoperatively. After surgery, the level of CYFRA21-1 was significantly decreased (from 33 to 5.0 ng/ml). Our case demonstrated that K19-positive primary cutaneous undifferentiated SCC induced high levels of CYFRA21-1 in the serum. Thus, CYFRA 21-1 may be a marker indicative of poorly differentiated cutaneous SCC exhibiting K19 expression.
引用
收藏
页码:986 / 988
页数:3
相关论文
共 50 条
  • [41] Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
    T Uenishi
    S Kubo
    K Hirohashi
    H Tanaka
    T Shuto
    T Yamamoto
    S Nishiguchi
    British Journal of Cancer, 2003, 88 : 1894 - 1899
  • [42] Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma
    Malhotra, Rewa
    Urs, Aadithya B.
    Chakravarti, Anita
    Kumar, Suman
    Gupta, V. K.
    Mahajan, Bhawna
    TUMOR BIOLOGY, 2016, 37 (07) : 9263 - 9271
  • [43] Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma
    Chen, S.
    Takahara, M.
    Kido, M.
    Takeuchi, S.
    Uchi, H.
    Tu, Y.
    Moroi, Y.
    Furue, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (04) : 952 - 955
  • [44] Cytokeratin 19 expression as a risk factor for metastasis in cutaneous squamous cell carcinoma.
    Uhara, Hisashi
    Kato, Junji
    Hida, Tokimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Serum fragment of cytokeratin subunit 19 (Cyfra) as a tumor marker in diagnosis and monitoring of treatment of oral squamous cell carcinoma
    Kurokawa H.
    Tokudome S.
    Yamashita Y.
    Ishibashi H.
    Yoshikawa T.
    Kajiyama M.
    International Journal of Clinical Oncology, 1999, 4 (1) : 17 - 21
  • [46] SERUM CYFRA 21-1 ASSAY IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    FERDEGHINI, M
    GADDUCCI, A
    ANNICCHIARICO, C
    PRONTERA, C
    MALAGNINO, G
    CASTELLANI, C
    FACCHINI, V
    BIANCHI, R
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1841 - 1844
  • [47] Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer
    Pang, Li
    Wang, Jing
    Jiang, Yanwen
    Chen, Liangan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (02) : 355 - 360
  • [48] Roles of squamous cell cancer antigen, cytokeratin 21-1 fragment, and carcinoembryonic antigen in the diagnosis and prognosis of postoperative locoregional recurrence in esophageal carcinoma
    Nie, Bin
    Sun, Wei
    Wang, Jian
    Yu, Jingping
    Sun, Suping
    Ni, Xinchu
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (05) : 552 - 561
  • [49] Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease
    Nakamura, Y.
    Tanese, K.
    Hirai, I.
    Amagai, M.
    Kawakami, Y.
    Funakoshi, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 535 - 543
  • [50] Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma
    Huang, MS
    Jong, SB
    Tsai, MS
    Lin, MS
    Chong, IW
    Lin, HC
    Hwang, JJ
    RESPIRATORY MEDICINE, 1997, 91 (03) : 135 - 142